LymeAlert
PrivateLast Round
Angel
Jan 4, 2026
Total Funding Raised
$70,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
LymeAlert operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was an Angel round in January 2026.
LymeAlert is a healthtech company that develops at-home rapid tick-testing diagnostic kits for the early detection of Lyme disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Telemedicine
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LymeAlert Comparables
Compare LymeAlert with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Better Life Science | 89% | |
| Ticknology, LLC | 79% | |
| TickCheck | 77% |
For institutional investors. Book with your work email.
LymeAlert Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jan 4, 2026 | ||||
| VC Round | Jan 1, 2026 | ||||
| VC Round | Sep 4, 2025 | ||||
| Grant | Feb 26, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LymeAlert Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDEAS Social Innovation Challenge | Grant |
| Bay Area Lyme Foundation | VC Round |
| Fortify Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 186% MoM, reaching 7.7K.
- Jun 26, 2026
Monthly visitors grew 113% MoM, reaching 3.2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 29, 2026
LymeAlert, a female-founded biotech startup developed by three MIT scholars, earns recognition on TIME’s Best Inventions of 2026 list in Massachusetts on Oct. 29th '26 for its rapid, at-home tick-testing technology.
- launchesAug 17, 2026
LymeAlert launches TickCrusher, a rapid at-home kit that detects Lyme-causing bacteria in ticks removed from people or pets in less than 30 minutes; the $50 kit is available for pre-order.
For institutional investors. Book with your work email.
LymeAlert Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LymeAlert's valuation, stock price, and market status.
Is LymeAlert a public or private company?
LymeAlert is a private company.
What is the current stock price of LymeAlert?
LymeAlert is a private company, so its shares have no public market price. Caplight tracks LymeAlert's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LymeAlert worth (valuation)?
Valuation information for LymeAlert is not publicly available.
Can I buy LymeAlert stock?
LymeAlert shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LymeAlert's last funding round?
LymeAlert's most recent funding round was Angel on January 4, 2026.
Who are the main investors in LymeAlert?
Key investors in LymeAlert include IDEAS Social Innovation Challenge, Bay Area Lyme Foundation, Fortify Ventures.
Will LymeAlert IPO soon?
No public IPO plans have been announced for LymeAlert.
How can I track LymeAlert secondary market activity?
Caplight tracks bids, offers, and trades in LymeAlert's shares on secondary markets.